Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform the management of sclerotic disease. To determine which biomechanical parameter(s) can accurately differentiate patients with sclerotic chronic g...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | JID Innovations |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667026721000370 |
id |
doaj-8b90ea82116f429ea9cfe4c66dbde546 |
---|---|
record_format |
Article |
spelling |
doaj-8b90ea82116f429ea9cfe4c66dbde5462021-10-03T04:44:37ZengElsevierJID Innovations2667-02672021-09-0113100037Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host DiseaseLaura X. Baker0Fuyao Chen1Austin Cronin2Heidi Chen3Arved Vain4Madan Jagasia5Eric R. Tkaczyk6Dermatology Service and Research Service, Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA; Vanderbilt Dermatology Translational Research Clinic, Vanderbilt University Medical Center, Nashville, Tennessee, USADermatology Service and Research Service, Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA; Vanderbilt Dermatology Translational Research Clinic, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, Tennessee, USA; Yale School of Medicine, Yale University, New Haven, Connecticut, USADermatology Service and Research Service, Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA; Vanderbilt Dermatology Translational Research Clinic, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, Tennessee, USAVanderbilt-Ingram Cancer Center, Nashville, Tennessee, USAInstitute of Physics, University of Tartu, Tartu, EstoniaVanderbilt-Ingram Cancer Center, Nashville, Tennessee, USADermatology Service and Research Service, Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA; Vanderbilt Dermatology Translational Research Clinic, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, Tennessee, USA; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA; Correspondence: Eric R. Tkaczyk, Dermatology Service and Research Service, Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs, 719 Thompson Lane, One Hundred Oaks Suite 26300, Nashville, Tennessee 37204, USA.Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform the management of sclerotic disease. To determine which biomechanical parameter(s) can accurately differentiate patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls, 15 patients with sclerotic chronic graft-versus-host disease and 11 post–hematopoietic cell transplant controls were measured with the myotonometer on 18 anatomic sites. Logistic regression and two machine learning algorithms (least absolute shrinkage and selection operator regression and random forest) were developed to classify subjects. In univariable analysis, frequency had the highest overfit-corrected area under the curve (0.91). Backward stepwise selection and random forest machine learning identified frequency and relaxation time as the optimal parameters for differentiating patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls. Least absolute shrinkage and selection operator regression selected the combination of frequency and relaxation time (overfit-corrected area under the curve = 0.87). Discriminatory ability was maintained when only the sites accessible while the patient is supine (12 sites) were used. We report the distribution of values for these highly discriminative biomechanical parameters, which could inform the assessment of disease severity in future quantitative biomechanical studies of sclerotic chronic graft-versus-host disease.http://www.sciencedirect.com/science/article/pii/S2667026721000370 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Laura X. Baker Fuyao Chen Austin Cronin Heidi Chen Arved Vain Madan Jagasia Eric R. Tkaczyk |
spellingShingle |
Laura X. Baker Fuyao Chen Austin Cronin Heidi Chen Arved Vain Madan Jagasia Eric R. Tkaczyk Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease JID Innovations |
author_facet |
Laura X. Baker Fuyao Chen Austin Cronin Heidi Chen Arved Vain Madan Jagasia Eric R. Tkaczyk |
author_sort |
Laura X. Baker |
title |
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease |
title_short |
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease |
title_full |
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease |
title_fullStr |
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease |
title_full_unstemmed |
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease |
title_sort |
optimal biomechanical parameters for measuring sclerotic chronic graft-versus-host disease |
publisher |
Elsevier |
series |
JID Innovations |
issn |
2667-0267 |
publishDate |
2021-09-01 |
description |
Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform the management of sclerotic disease. To determine which biomechanical parameter(s) can accurately differentiate patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls, 15 patients with sclerotic chronic graft-versus-host disease and 11 post–hematopoietic cell transplant controls were measured with the myotonometer on 18 anatomic sites. Logistic regression and two machine learning algorithms (least absolute shrinkage and selection operator regression and random forest) were developed to classify subjects. In univariable analysis, frequency had the highest overfit-corrected area under the curve (0.91). Backward stepwise selection and random forest machine learning identified frequency and relaxation time as the optimal parameters for differentiating patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls. Least absolute shrinkage and selection operator regression selected the combination of frequency and relaxation time (overfit-corrected area under the curve = 0.87). Discriminatory ability was maintained when only the sites accessible while the patient is supine (12 sites) were used. We report the distribution of values for these highly discriminative biomechanical parameters, which could inform the assessment of disease severity in future quantitative biomechanical studies of sclerotic chronic graft-versus-host disease. |
url |
http://www.sciencedirect.com/science/article/pii/S2667026721000370 |
work_keys_str_mv |
AT lauraxbaker optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease AT fuyaochen optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease AT austincronin optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease AT heidichen optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease AT arvedvain optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease AT madanjagasia optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease AT ericrtkaczyk optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease |
_version_ |
1716846277731287040 |